ADC Therapeutics SA (ADCT)
USD 1.91
(-10.33%)
USD 1.91
(-10.33%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 69.55 Million | 209.9 Million | 33.91 Million | - | 2.34 Million | 1.14 Million |
| Cost of Revenue | 2.52 Million | 4.57 Million | 1.39 Million | 1.97 Million | 107.53 Million | 118.08 Million |
| Gross Profit | 67.02 Million | 205.32 Million | 32.52 Million | -1.97 Million | -105.19 Million | -116.94 Million |
| Operating Expenses | 233.01 Million | 328.95 Million | 294.24 Million | 219.26 Million | 121.73 Million | 127.08 Million |
| Selling, General and Administrative Expenses | 105.88 Million | 141.05 Million | 136.24 Million | 77.23 Million | 13.81 Million | 8.6 Million |
| Research and Development Expenses | 127.12 Million | 187.89 Million | 158 Million | 142.03 Million | 107.53 Million | 118.31 Million |
| Other Expenses | - | 14.57 Million | 28.48 Million | -46.39 Million | 388 Thousand | 166 Thousand |
| Cost and Expenses | 235.54 Million | 333.53 Million | 295.63 Million | 219.26 Million | 121.73 Million | 127.08 Million |
| Operating Income | -165.98 Million | -123.62 Million | -261.72 Million | -219.26 Million | -119.39 Million | -125.94 Million |
| Interest Expense | 46.32 Million | 36.92 Million | 18.34 Million | 4.92 Million | 156 Thousand | - |
| Income Tax Expense | 39.1 Million | 1.13 Million | -21.47 Million | 327 Thousand | 582 Thousand | 224 Thousand |
| Earnings before Tax | -195.41 Million | -154.66 Million | -251.5 Million | -245.96 Million | -115.9 Million | -122.87 Million |
| Net Income | -240.05 Million | -155.8 Million | -230.02 Million | -246.29 Million | -116.48 Million | -123.09 Million |
| Earnings Per Share Basic | -2.94 | -1.99 | -3.00 | -3.77 | -1.74 | -2.29 |
| Earnings Per Share Diluted | -2.94 | -1.99 | -3.00 | -3.77 | -1.74 | -2.29 |
| Weighted Average Shares Outstanding | 81.71 Million | 78.15 Million | 76.74 Million | 65.41 Million | 66.87 Million | 53.83 Million |
| Weighted Average Shares Outstanding (Diluted) | 81.71 Million | 78.15 Million | 76.74 Million | 65.41 Million | 66.87 Million | 53.83 Million |
| Gross Margin | 0.96 | 0.98 | 0.96 | - | -44.96 | -102.58 |
| EBIT Margin | -2.11 | -0.47 | -6.87 | - | -48.65 | -110.01 |
| Profit Margin | -3.45 | -0.74 | -6.78 | - | -49.78 | -107.98 |
| EBITDA | -146.76 Million | -108.05 Million | -223.71 Million | -219.26 Million | -114.1 Million | -122.35 Million |
| Earnings Before Tax Margin | -2.39 | -0.59 | -7.72 | - | -51.03 | -110.47 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 17.41 Million | 18.05 Million | 16.79 Million | 69.55 Million | 14.49 Million | 19.28 Million |
| Cost of Revenue | 2.05 Million | 3.35 Million | 1.21 Million | 2.52 Million | 366 Thousand | 1.31 Million |
| Gross Profit | 15.35 Million | 14.7 Million | 15.57 Million | 67.02 Million | 14.12 Million | 17.96 Million |
| Operating Expenses | 44.39 Million | 48.31 Million | 55.55 Million | 233.01 Million | 51.53 Million | 57.75 Million |
| Selling, General and Administrative Expenses | 20.1 Million | 22.57 Million | 25.22 Million | - | 23.09 Million | 12.59 Million |
| Research and Development Expenses | 24.29 Million | 25.73 Million | 30.33 Million | - | 28.44 Million | 31.94 Million |
| Other Expenses | 2.23 Million | 263 Thousand | 3.77 Million | 5.46 Million | 683 Thousand | 296 Thousand |
| Cost and Expenses | 46.45 Million | 51.66 Million | 56.76 Million | 235.54 Million | 51.89 Million | 59.07 Million |
| Operating Income | -29.04 Million | -33.61 Million | -39.97 Million | -165.98 Million | -37.4 Million | -39.78 Million |
| Interest Expense | 12.67 Million | 12.49 Million | 12.9 Million | 46.32 Million | 12.94 Million | 15.85 Million |
| Income Tax Expense | -86 Thousand | -84 Thousand | 43.17 Million | 39.1 Million | -86 Thousand | -6.61 Million |
| Earnings before Tax | -36.03 Million | -46 Million | -39.87 Million | -195.41 Million | -47.89 Million | -53.72 Million |
| Net Income | -36.54 Million | -46.6 Million | -85.03 Million | -240.05 Million | -47.8 Million | -47.11 Million |
| Earnings Per Share Basic | -0.38 | -0.56 | -1.03 | - | -0.58 | -0.58 |
| Earnings Per Share Diluted | -0.38 | -0.56 | -1.03 | - | -0.58 | -0.58 |
| Weighted Average Shares Outstanding | 95.69 Million | 82.55 Million | 82.29 Million | 81.71 Million | 82.25 Million | 81.47 Million |
| Weighted Average Shares Outstanding (Diluted) | 95.69 Million | 82.55 Million | 82.29 Million | 81.71 Million | 82.25 Million | 81.47 Million |
| Gross Margin | 0.88 | 0.81 | 0.93 | 0.96 | 0.97 | 0.93 |
| EBIT Margin | -1.62 | -1.82 | -1.51 | - | -2.36 | -1.92 |
| Profit Margin | -2.10 | -2.58 | -5.06 | -3.45 | -3.30 | -2.44 |
| EBITDA | -28.2 Million | -32.77 Million | -25.36 Million | - | -34.19 Million | -37.11 Million |
| Earnings Before Tax Margin | -1.67 | -1.86 | -2.38 | -2.39 | -2.58 | -2.06 |
ACF
PTCIL
GUJALKALI
TITANSEC
PGXFF
600628